Literature DB >> 22297882

Patients with sudden onset headache not meeting the criteria of the International Headache Society for new daily persistent headache. How to classify them?

Paulo Hélio Monzillo1, Patrícia Homsi Nemoto.   

Abstract

We conducted a retrospective analysis of the records of 1348 patients regularly treated at the headache clinic of Department of Neurology of Santa Casa de São Paulo, Brazil. Sixty-two patients reported history of daily and persistent headache. From the 62 patients selected, only 21 (group 1) could be diagnosed with new daily-persistent headache (NDPH) according to the International Headache Society (HIS) 2004 criteria. The 41 remaining patients (group 2) could not be diagnosed with NDPH according to IHS-2004 once they presented two or more migraine attack-related symptoms, such as: nausea, photophobia, phonophobia and vomiting, in different combinations. It was not possible to classify them in groups 1 to 4 of primary headaches either. How to classify them? We suggest that the criteria are revised. And one way we can classify them, would be the subdivision: NDPH with migraine features and without migraine features that would allow the inclusion of all individuals present who has a daily and persistent headache from the beginning.

Entities:  

Mesh:

Year:  2011        PMID: 22297882     DOI: 10.1590/s0004-282x2011000700016

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Refining clinical features and therapeutic options of new daily persistent headache: a retrospective study of 63 patients in India.

Authors:  Sanjay Prakash; Samir Saini; Kaushikkumar Ramanlal Rana; Pinaki Mahato
Journal:  J Headache Pain       Date:  2012-05-27       Impact factor: 7.277

2.  Diagnostic criteria for temporomandibular disorders: self-instruction or formal training and calibration?

Authors:  Larissa Soares Reis Vilanova; Renata Cunha Matheus Rodrigues Garcia; Thomas List; Per Alstergren
Journal:  J Headache Pain       Date:  2015-03-25       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.